Concepedia

Author

D Venzon

National Cancer Institute

Also Known As

D J Venzon, D Venzon, D. Venzon, DJ Venzon

8

Publications

1K

Citations

7

H-Index

24

Concepts

All Affiliations

National Cancer InstituteNational Institutes of Health
DV

About

D Venzon is an author at National Cancer Institute specializing in medicine, toxicology, and limb lengthening.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

318

2

Public Health

1

1

225

3

Immunology

1

1

82

4

Orthopaedics

1

1

11

5

Pathology

1

1

82

D Venzon

×

7

Publications

1K

Citations

7

H-Index

YearCitations

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

Ian Magrath, Magdalena Adde, Aziza Shad,

Journal of Clinical Oncology

1996

485

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.

Leonard H. Wexler, Mary P. Andrich, D Venzon,

Journal of Clinical Oncology

1996

225

Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats.

H. Richard Alexander, Gerard M. Doherty, D Venzon,

PubMed

1992

87

Role of tumor necrosis factor in oxygen toxicity

J C Jensen, Helen W. Pogrebniak, Harvey I. Pass,

Journal of Applied Physiology

1992

82

Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.

Melissa Adde, Aziza Shad, D Venzon,

PubMed

1998

71

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

Michael Weintraub, Magdalena Adde, D Venzon,

Journal of Clinical Oncology

1996

64

Acute and long term effects on limb function of combined modality therapy in patients treated with limb sparing surgery for soft tissue sarcoma of the extremity

Scott Stinson, Thomas F. DeLaney, Jyh‐Chin Yang,

International Journal of Radiation Oncology*Biology*Physics

1990

11

Page 1